Project Grant K24HL175228
Award Date
8/15/24
Completion Date
6/30/29
Dollars Obligated
$117K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
The Johns Hopkins University was awarded a $648,073 federal Project Grant from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) to conduct the ADHINCRA study: Addressing Hypertension Care in Africa. The project aims to implement and evaluate multilevel interventions, including team-based care and digital health technologies, to improve hypertension control in Ghana and Nigeria. Key activities will involve deploying a remote telemonitoring application...
This federal Project Grant award of $633,755.00 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to develop and implement an integrated community-based approach called "Community Vital Signs (CVS)" to increase rates of blood pressure screening and connections to care for hypertension in Nigeria. The award supports a two-phase project. In the R61 phase (Year 1), the grantee, Oregon Health & Science University, will engage...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,321,108 Project Grant under CFDA 93.837 (Cardiovascular Diseases Research) to New York University School of Medicine to conduct transdisciplinary implementation research on a strategy called PT4A. PT4A integrates peer-based medication delivery, peer coaching, and health information technology to improve medication adherence and reduce blood pressure among patients with uncontrolled hypertension in Western Kenya. The study aims to...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $162,820 to New York University School of Medicine to conduct research aimed at developing a community-based strategy to link people living with HIV (PLWH) and comorbid hypertension to primary healthcare centers for hypertension management in Akwa Ibom, Nigeria. The key objectives of this 5-year project, titled "Leveraging...
The Washington University in St. Louis has been awarded a $498,129.23 federal Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant, with a period of performance from December 9, 2024 to November 30, 2027, aims to evaluate the implementation of a heart failure (HF) polypill treatment strategy in India. The project will first conduct formative research to guide the development of the HF polypill...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,314,024 Project Grant under CFDA 93.837 Cardiovascular Diseases Research to Weill Medical College of Cornell University to implement the "Coaching and Navigation by CHWs through Telehealth for High-Risk Hypertension" (CONNECT-HTN) intervention. The project aims to reduce death and hospitalization due to heart disease or stroke by connecting patients with severe hypertension to primary care resources and providing...
This $100,558 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research Program (CFDA 93.837) will support a series of prospective, multimodal cardiovascular research studies to be conducted by Stellenbosch University in South Africa. The research aims to explore the underlying mechanisms of cardiovascular disease (CVD) in people living with HIV (PLWH), investigate the inflammatory pathways associated with heart muscle edema and...
This federal Project Grant award, totaling $727,972.00, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The primary awardee, Vanderbilt University Medical Center, will conduct research to understand racial/ethnic disparities in clinician concordance with hypertension treatment guidelines and blood pressure control. The project aims to: 1) evaluate the extent of racial disparities in hypertension treatment...
The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $674,300 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to The Washington University in St. Louis. The award, effective February 1, 2025 through November 30, 2028, will support a comprehensive, three-phase study to examine the system-wide implementation of new flexibilities to the National School Lunch and Breakfast Programs (NSLP/SBP). The research aims to assess current practices,...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $290,881 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Trustees of Indiana University, doing business as Indiana University Indianapolis (IU Indianapolis). The grant, titled "INDIANA STIMULATING ACCESS TO RESEARCH IN RESIDENCY (I-STARR)", aims to train up to 12 resident-physicians from primary care residency programs in research methods focused on understanding and reducing health...